Stockreport

IMUNON Reports Compliance with Nasdaq Listing Requirements [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today announced that on April 10, 2024, it received written notice fro [Read more]